🇺🇸 MRK — Merck & Co., Inc.

Healthcare Compra
← Volver

Precio actual

150,33 USD

Máx. histórico

156,92

10 días

Split 1048:1000 del 03/06/2021

Caída desde máximo

-4,20%

Rango 52 semanas

77,58 – 156,92

Variación hoy

-1,32%

Cierre anterior

152,34

Rango de hoy

150,09 – 152,22

Volumen hoy

4.298.143

Información
Nombre completo
Merck & Co., Inc.
Divisa
USD
Mercado
NYSE
Sector
Healthcare
Industria
Drug Manufacturers - General
Empleados
73.000
PER ⓘ
120,26 (puede no estar actualizado)
Dividend yield
2,23% (puede no estar actualizado)
Precio objetivo analistas
149,50 USD (puede no estar actualizado)
Primera cotización
02/01/1962
Precio actualizado
hace 3 días
Sobre la empresa

Merck & Co., Inc. operates as a healthcare company worldwide. It offers human health pharmaceutical for various areas under the Keytruda, Keytruda Qlex, Welireg, Gardasil, ProQuad, M-M-R II, Varivax, Vaxneuvance, Capvaxive, RotaTeq, Pneumovax 23, Bridion, Prevymis, Dificid, Zerbaxa, Winrevair, Adempas/ Verquvo, Ohtuvayre, Lagevrio, Isentress/Isentress HD, Delstrigo, Pifeltro, Belsomra, Januvia, and Janumet brands. The company also provides veterinary pharmaceuticals, vaccines and health management solutions and services, such as livestock products under the Nuflor, Bovilis/Vista, Bovilis Cryptium, Banamine, Estrumate, Matrix, Resflor, Zuprevo, Revalor, Safe-Guard, M+Pac, Porcilis, Circumvent, Nobilis/Innovax, Paracox and Coccivac, Exzolt, Slice, Imvixa, Clynav, Aquavac/Norvax, Aquaflor, Flexolt brands; Allflex Livestock Intelligence solutions; and companion animal products under the Bravecto One-Month, Bravecto Injectable/Quantum, Bravecto TriUNO, Bravecto Plus, Sentinel Spectrum, Sentinel Flavor Tabs, Numelvi, Optimmune, Nobivac NXT, GilvetMab, Otomax, Mometamax, Mometamax Ultra, Posatex, Caninsulin/Vetsulin, Panacur, Safeguard, Regumate, Prestige, Scalibor/Exspot, Sure Petcare, and Home Again brands. It has development and commercialization agreement for three of Daiichi Sankyo's deruxtecan ADC candidates; AstraZeneca PLC to co-development and co-commercialize AstraZeneca's Lynparza products for multiple cancer types; licensed to develop, manufacture and commercialize LM-299, a novel investigational PD-1/VEGF bispecific antibody from LaNova; and collaboration agreement with Eisai Co., Ltd., Bayer AG, and Ridgeback Biotherapeutics LP, as well Moderna, Inc. Merck & Co., Inc. has strategic collaboration with Infinimmune, Inc. to discover and develop antibodies against multiple therapeutic targets. The company was founded in 1891 and is headquartered in Rahway, New Jersey.

Dividendos repartidos Total últimos 12 meses: 3,3600 USD · Yield: 2,24%
Fecha de pago Importe por participación
12/03/2015 0,4294 USD
11/12/2014 0,4294 USD
11/09/2014 0,4198 USD
12/06/2014 0,4198 USD
13/03/2014 0,4198 USD
12/12/2013 0,4198 USD
12/09/2013 0,4103 USD
13/06/2013 0,4103 USD
13/03/2013 0,4103 USD
13/12/2012 0,4103 USD
13/09/2012 0,4008 USD
13/06/2012 0,4008 USD
13/03/2012 0,4008 USD
13/12/2011 0,4008 USD
13/09/2011 0,3626 USD
Splits Registrados en el histórico de precios
Fecha Ratio
03/06/2021 1048:1000
17/02/1999 2:1
26/05/1992 3:1
26/05/1988 3:1
27/05/1986 2:1
01/06/1972 2:1
Rentabilidad mensual
Evolución
Histórico día a día
Fecha Apertura Máximo Mínimo Cierre Variación Volatilidad día Volumen
29/09/1989 12,09 12,11 11,93 12,05 -0,66% 1,48% 4.646.832
28/09/1989 11,81 12,13 11,81 12,13 +3,04% 2,69% 7.150.085
27/09/1989 11,31 11,77 11,29 11,77 +4,04% 4,22% 5.658.571
26/09/1989 11,43 11,47 11,29 11,31 -0,70% 1,57% 4.673.870
25/09/1989 11,41 11,43 11,35 11,39 -0,69% 0,70% 3.313.776
22/09/1989 11,49 11,51 11,41 11,47 +0,17% 0,87% 2.539.094
21/09/1989 11,61 11,61 11,43 11,45 +0,00% 1,54% 3.171.667
20/09/1989 11,41 11,47 11,37 11,45 +0,00% 0,87% 2.839.032
19/09/1989 11,39 11,45 11,37 11,45 +0,70% 0,70% 2.905.056
18/09/1989 11,29 11,41 11,27 11,37 +0,88% 1,23% 3.627.547
15/09/1989 11,21 11,31 11,15 11,27 +0,71% 1,42% 9.985.344
14/09/1989 11,29 11,31 11,11 11,19 -0,71% 1,76% 5.823.317
13/09/1989 11,37 11,41 11,27 11,27 -0,70% 1,22% 6.159.725
12/09/1989 11,37 11,45 11,33 11,35 -0,70% 1,05% 3.594.221
11/09/1989 11,33 11,43 11,25 11,43 +1,41% 1,58% 4.079.654
08/09/1989 11,39 11,41 11,21 11,27 -0,35% 1,75% 6.471.610
07/09/1989 11,53 11,57 11,25 11,31 -1,56% 2,76% 6.023.275
06/09/1989 11,63 11,65 11,37 11,49 -1,37% 2,39% 7.822.272
05/09/1989 11,75 11,77 11,63 11,65 -0,68% 1,18% 4.418.578
01/09/1989 11,75 11,91 11,71 11,73 +0,51% 1,69% 4.475.170
31/08/1989 11,67 11,73 11,57 11,67 +0,00% 1,36% 4.007.971
30/08/1989 11,81 11,83 11,65 11,67 -1,01% 1,52% 3.782.861
29/08/1989 11,83 11,91 11,71 11,79 -0,50% 1,68% 4.057.646
28/08/1989 11,81 11,87 11,75 11,85 +0,51% 1,01% 3.656.472
25/08/1989 11,95 11,99 11,77 11,79 -1,33% 1,83% 3.599.880
24/08/1989 11,79 11,95 11,69 11,95 +1,18% 2,19% 8.024.746
23/08/1989 11,81 11,83 11,69 11,81 +1,02% 1,18% 5.472.446
22/08/1989 11,79 11,81 11,59 11,69 -1,34% 1,86% 4.846.162
21/08/1989 11,99 12,01 11,77 11,85 -1,32% 1,99% 3.560.894
18/08/1989 11,99 12,05 11,97 12,01 -0,49% 0,66% 4.985.755